BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34571599)

  • 21. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
    Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S
    Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.
    Rishi P; Sharma T; Sharma M; Maitray A; Dhami A; Aggarwal V; Munusamy S; Ravikumar R; Ramamurthy S
    Indian J Ophthalmol; 2017 Apr; 65(4):311-315. PubMed ID: 28513496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes in retinoblastoma, 1974-2005: the Children's Hospital, Westmead.
    Berman EL; Donaldson CE; Giblin M; Martin FJ
    Clin Exp Ophthalmol; 2007; 35(1):5-12. PubMed ID: 17300564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
    Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
    Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes.
    Fabian ID; Naeem Z; Stacey AW; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
    Am J Ophthalmol; 2017 Jul; 179():137-144. PubMed ID: 28501391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and outcome of unilateral retinoblastoma.
    Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
    J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical profile, management, and outcome of retinoblastoma in singapore.
    Lim FP; Soh SY; Iyer JV; Tan AM; Swati H; Quah BL
    J Pediatr Ophthalmol Strabismus; 2013; 50(2):106-12. PubMed ID: 23244241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eye-preserving therapy in retinoblastoma: prolonged primary chemotherapy alone or combined with local therapy.
    Shin JY; Kim JH; Yu YS; Khwarg SI; Choung HK; Shin HY; Ahn HS
    Korean J Ophthalmol; 2010 Aug; 24(4):219-24. PubMed ID: 20714385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trilateral retinoblastoma: a literature review, 1971-2004.
    Mouratova T
    Bull Soc Belge Ophtalmol; 2005; (297):25-35. PubMed ID: 16281731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes.
    Dondey JC; Staffieri S; McKenzie J; Davie G; Elder J
    Clin Exp Ophthalmol; 2004 Aug; 32(4):354-9. PubMed ID: 15281966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extra-ocular retinoblastoma: about 12 cases followed at the Mohamed VI university hospital of Marrakech.
    Leila S; Ibtissam H; Hafsa E; Abdeljalil M
    Pan Afr Med J; 2016; 25():131. PubMed ID: 28292093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retinoblastoma update].
    Aerts I; Lumbroso-Le Rouic L; Gauthier-Villars M; Brisse H; Doz F
    Arch Pediatr; 2016 Jan; 23(1):112-6. PubMed ID: 26679524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retinoblastoma: preliminary results of national treatment protocol at Casablanca university medical center].
    El Kettani A; Aderdour S; Daghouj G; Knari S; Zaghloul K; Zafad S; Harif M; Benchekroun S
    J Fr Ophtalmol; 2014 Feb; 37(2):115-24. PubMed ID: 24507074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NEWLY DIAGNOSED ACTIVE RETINOBLASTOMA IN ADULTS.
    Kaliki S; Shields CL; Gupta A; Mishra DK; Das C; Say EA; Shields JA
    Retina; 2015 Dec; 35(12):2483-8. PubMed ID: 26035399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.
    Ozdemir H; Tacyildiz N; Unal E; Yavuz G; Ugur H; Gunduz K
    Pediatr Hematol Oncol; 2007; 24(3):221-31. PubMed ID: 17454793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examinations under anaesthesia as a measure of disease burden in unilateral retinoblastoma: the London experience.
    Fabian ID; Shah V; Kapelushnik N; Naeem Z; Onadim Z; Price E; Chowdhury T; Duncan C; Stansfield D; Sagoo M; Reddy MA
    Br J Ophthalmol; 2020 Jan; 104(1):17-22. PubMed ID: 30862620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
    O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
    Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China.
    Zhao J; Li S; Shi J; Wang N
    Br J Ophthalmol; 2011 Oct; 95(10):1372-5. PubMed ID: 21252083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.